Correlation Between Iovance Biotherapeutics and Cingulate

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Cingulate at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Cingulate into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and Cingulate, you can compare the effects of market volatilities on Iovance Biotherapeutics and Cingulate and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Cingulate. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Cingulate.

Diversification Opportunities for Iovance Biotherapeutics and Cingulate

-0.12
  Correlation Coefficient

Good diversification

The 3 months correlation between Iovance and Cingulate is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Cingulate in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cingulate and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Cingulate. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cingulate has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Cingulate go up and down completely randomly.

Pair Corralation between Iovance Biotherapeutics and Cingulate

Given the investment horizon of 90 days Iovance Biotherapeutics is expected to under-perform the Cingulate. In addition to that, Iovance Biotherapeutics is 1.1 times more volatile than Cingulate. It trades about -0.1 of its total potential returns per unit of risk. Cingulate is currently generating about 0.02 per unit of volatility. If you would invest  422.00  in Cingulate on September 15, 2024 and sell it today you would earn a total of  0.00  from holding Cingulate or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Iovance Biotherapeutics  vs.  Cingulate

 Performance 
       Timeline  
Iovance Biotherapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Iovance Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Cingulate 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cingulate has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Iovance Biotherapeutics and Cingulate Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Iovance Biotherapeutics and Cingulate

The main advantage of trading using opposite Iovance Biotherapeutics and Cingulate positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Cingulate can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cingulate will offset losses from the drop in Cingulate's long position.
The idea behind Iovance Biotherapeutics and Cingulate pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges